View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
July 16, 2018

US researchers create device to detect mosquito-borne diseases

Researchers at SMK Diagnostics, the Purdue University startup, have developed a biosensor that can quickly identify mosquito-borne diseases prior to the transmission of the viruses to humans.

Researchers at SMK Diagnostics, the Purdue University startup, have developed a biosensor that can quickly identify mosquito-borne diseases prior to the transmission of the viruses to humans.

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

The sensor has been designed to detect and monitor viruses such as Zika and dengue, but cannot be used for bacteria-based diseases, including malaria.

The technology involves an electrode that can immobilise certain biological molecules which bind to the virus RNA. This binding of DNA or RNA of a virus-infected mosquito to the electrode changes its surface resistance, enabling the determination of the presence of a virus.

“Purdue Office of Technology Commercialisation aided SMK Diagnostics in obtaining a patent for the technology. The startup is now working towards securing funding to develop a prototype of the sensor.”

While existing approaches to detect mosquito-borne diseases are time-consuming and require one week or more to identify the type of virus, the new sensor is said to possess the capability to differentiate specific flaviviruses within one hour.

Purdue University Materials Engineering associate head and professor Lia Stanciu said: “The sensor provides early detection so you can intervene earlier. Only the virus will bind to the surface, no other molecules. It is recognition, like a key and lock.”

The researchers hope to use the biosensor technology in regions populated with disease-carrying mosquitoes in order to help local agencies in identifying the danger and enable them to take preventive measures.

Stanciu added: “That way local agencies know there is a danger so they can take action to eradicate the virus before it spreads to people.”

Purdue Office of Technology Commercialisation aided SMK Diagnostics in obtaining a patent for the technology. The startup is now working towards securing funding to develop a prototype of the sensor.

Related Companies

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network